Forbes ranking of top employers drawn from a survey of 30,000 US employees in 25 industry sectors

Dublin, Ireland, 11 May 2017ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been included in Forbes magazine’s America’s Best Employers list for 2017.

Now in its third year, the Forbes list features the top 500 large employers in the US with more than 5,000 employees and the top 300 midsize companies with 1,000 – 5,000 employees. ICON was the highest ranked CRO in the best midsize employers listing.

The Forbes list is determined following an independent, online survey of 30,000 employees representing companies from 25 industry sectors. In conjunction with consumer research provider, Statista, employees were consulted anonymously in September 2016 through several online panels to allow them to share their opinions about their employers openly and without any influence from their employer. Respondents were asked to rate their willingness to recommend their own companies on a scale of 0 – 10 and were also asked to name good and bad employers in industry sectors other than their own.

“We are proud to be named by Forbes as one of the best employers in America and we are pleased that our employees are recommending ICON as an excellent place to work,” commented Dr. Steve Cutler, Chief Executive Officer, ICON. “We have great people who are committed to helping our clients to accelerate the development of drugs and devices that are saving lives and improving the quality of life of patients right across the globe. We will continue to work hard to ensure that we provide a work environment that engages, rewards and develops our employees so that they can build successful careers at ICON.”

About ICON
ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 87 locations in 38 countries and has approximately 12,300 employees. Further information is available at

ICON Media Contact
Camille Frederix
Weber Shandwick
Tel: +44 (0)207 067 0272

Leave a Reply